Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-054 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for an Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) to provide a broad range of support critical for design, development, execution, and analysis of clinical research in allergic diseases and asthma. The major clinical research programs to be supported by the AA-SCCC include the Atopic Dermatitis Research Network, Consortium for Food Allergy Research, Childhood Asthma in Urban Settings Clinical Research Network, and Immune Tolerance Network. The AA-SCCC also may s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2022 Category: Research Source Type: funding
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
Funding Opportunity RFA-AI-21-079 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allerg...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2021 Category: Research Source Type: funding
SUNBEAM - Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-21-060 from the NIH Guide for Grants and Contracts. The purpose of the SUNBEAM - Analysis and Bioinformatics Center (SUNBEAM-ABC) is to establish a mechanistic omics center to support the birth cohort study Systems Biology of Early Atopy (SUNBEAM). The center will assay biologic samples collected within the SUNBEAM cohort using omics and systems biology approaches to identify determinants of atopic disease, focusing on food allergy and atopic dermatitis (AD) in newborns, infants, and very young children. SUNBEAM-ABC will support the SUNBEAM birth cohort study by providing analytic infrastructu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 20, 2021 Category: Research Source Type: funding
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
Funding Opportunity RFA-AI-20-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allerg...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 23, 2020 Category: Research Source Type: funding
Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-015 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID Atopic Dermatitis Research Network Clinical Research Centers (ADRN-CRCs). The ADRN-CRCs will conduct the ADRN network-wide clinical research projects under the leadership of the ADRN Leadership Center (ADRN-LC). In parallel, each ADRN-CRC will pursue its own clinical research program in support of the scientific goals of the ADRN. To achieve the ADRN objectives, the ADRN-CRCs will work closely with the ADRN-LC. (Source: NIH Funding Opportunitie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2019 Category: Research Source Type: funding
Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required
Funding Opportunity RFA-AI-19-014 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID Atopic Dermatitis Research Network Leadership Center (ADRN-LC) for the NIAID ADRN. The ADRN-LC will provide the overall scientific strategy and organizational structure to the ADRN and will interact closely with the ADRN Clinical Research Centers (ADRN-CRCs), to support the conduct of multi-site clinical studies and trials under the ADRN. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2019 Category: Research Source Type: funding
Seeking Input on the Need to Enhance Access to NIH Grants Data
NIH has long been
committed to transparency into who and what we fund. We have previously
discussed the value of freely-available web tools that allow
you to gain insight into NIH funding decisions. Award data available via RePORT
and RePORTER, for
instance, include non-sensitive information such as awardee institution,
principal investigator, funding levels, research abstracts, as well as
associated publications, patents, and other project outcomes. Better yet, if
you want to see all of these data all at once, then ExPORTER
allows you to download over 25 years’ worth of such non-sensitive NIH grant
award data.
Resea...
Source: NIH Extramural Nexus - March 4, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike Administrative Data Data enclave RFI Source Type: funding
Update in Funds Application Due Date(s) and Expiration Date Sections of RFA-FD-08-019 - Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)
Notice NOT-FD-18-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 24, 2018 Category: Research Source Type: funding
Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems
Funding Opportunity RFA-FD-18-019 from the NIH Guide for Grants and Contracts. The purpose of this project is to incorporate drug product quality attributes into dermal physiologically-based pharmacokinetic models developed for dermatological topical dosage forms and transdermal delivery systems. The developed models will be utilized to identify drug-product specific critical quality attributes (model qualification) and perform virtual bioequivalence assessments between brand name and generic drug products to inform regulatory decisions relating to the development of dermatological drug products. (Source: NIH Funding Op...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2018 Category: Research Source Type: funding
Characterize skin physiology parameters utilized in dermal physiologically-based pharmacokinetic model development across different skin disease states
Funding Opportunity RFA-FD-18-017 from the NIH Guide for Grants and Contracts. The purpose of this project is to identify skin physiology characteristics that differ between healthy and skin disease population groups and incorporate them into dermal physiologically-based pharmacokinetic models to improve their predictability. The models developed will be utilized to perform virtual bioequivalence assessments between brand name and generic drug products to inform regulatory decisions relating to the development of generic topical dermatological drug products and transdermal delivery systems. (Source: NIH Funding Opportun...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 20, 2018 Category: Research Source Type: funding
Building Systems and Capacity within the Cambodian Ministry of Health to Prevent New HIV Infections and AIDS-Related Deaths in Cambodia through PEPFAR Support to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) under the President ’s Emer..
Funding Opportunity ID: 289171 Opportunity Number: CDC-RFA-GH13-130305CONT17 Opportunity Title: Building Systems and Capacity within the Cambodian Ministry of Health to Prevent New HIV Infections and AIDS-Related Deaths in Cambodia through PEPFAR Support to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) under the President’s Emer..Opportunity Category: ContinuationOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.067Eligible Applicants: Others (see text field entitled "Additional...
Source: Grants.gov - September 27, 2016 Category: Research Tags: Health Source Type: funding
Asthma and Allergic Diseases Cooperative Research Centers (U19)
Funding Opportunity ID: 287269 Opportunity Number: RFA-AI-16-065 Opportunity Title: Asthma and Allergic Diseases Cooperative Research Centers (U19)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.85593.856Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public...
Source: Grants.gov - August 11, 2016 Category: Research Tags: Health Source Type: funding
Asthma and Allergic Diseases Cooperative Research Centers (U19)
Funding Opportunity RFA-AI-16-065 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and basic research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The o...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 10, 2016 Category: Research Source Type: funding
Bioequivalence of Topical Products: Comparing Dermal Pharmacokinetics by Microdialysis or Microperfusion Techniques (U01)
Funding Opportunity Number: RFA-FD-16-028 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Consumer ProtectionFood and NutritionHealthCFDA Number: 93.103Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal govern...
Source: Grants.gov - April 2, 2016 Category: Research Tags: Consumer Protection Food and Nutrition Health Source Type: funding
Bioequivalence of Topical Products: Comparing Dermal Pharmacokinetics by Microdialysis or Microperfusion Techniques (U01)
Funding Opportunity RFA-FD-16-028 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to support the research and development necessary to advance microdialysis or open flow microperfusion methods, study designs, and analyses to directly measure the rate and extent to which a topically applied compound becomes available in the dermis, at or near a site of action within the skin. The expectation is that the funded work will produce an accurate, sensitive and reproducible approach that measures the amount of drug present in the dermis over time. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 25, 2016 Category: Research Source Type: funding
